Elimination of cell-cycle regulators during caspase-3-dependent apoptosis caused by an immunosuppressant, FTY720

被引:12
作者
Lee, YS
Nakajima, H
Tsuruga, M
Magae, J
机构
[1] Inst Res & Innovat, Dept Biotechnol, Kashiwa, Chiba 2270861, Japan
[2] Natl Inst Biosci & Human Technol, Tsukuba, Ibaraki 3058566, Japan
[3] Kyoto Prefectural Univ Med, Lab Breast Surg, Dept Endocrine, Kamikyo Ku, Kyoto 6020841, Japan
关键词
apoptosis; FTY720; caspase; cell-cycle; pRb;
D O I
10.1271/bbb.67.467
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The immunosuppressant, FTY720 causes apoptosis of lymphocytes, reduces. numbers of lymphocytes in peripheral blood, and prevents infiltration of lymphocytes into allografts, which may be one of the mechanisms involved in its effects. Here we compared caspase activation and expression of cell-cycle regulators during apoptosis caused by FTY720, and Fas-stimulation in a mouse lymphoma transfected with human Fas antigen. FTY720 activated caspases-3, -8, and -9 as rapidly as did Fas-mediated apoptosis. The activation was blocked by a peptide inhibitor for caspase-3, DEVD-CHO. Fas-induced activation of caspases-8 and -9 was unaffected by the inhibitor. FTY720 eliminated proliferating cell nuclear antigen, retinoblastoma family members, differentiation regulated transcription factor polypetide-1, and cyclin H. These cell-cycle regulators were not eliminated when the peptide inhibitor was used. Dysfunction of cell-cycle regulators may play a critical role in the signal transduction pathway for activation of FTY720-mediated apoptosis.
引用
收藏
页码:467 / 474
页数:8
相关论文
共 46 条
[1]   DESIGN, SYNTHESIS, AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2-SUBSTITUTED-2-AMINO-1,3-PROPANEDIOLS - DISCOVERY OF A NOVEL IMMUNOSUPPRESSANT, FTY720 [J].
ADACHI, K ;
KOHARA, T ;
NAKAO, N ;
ARITA, M ;
CHIBA, K ;
MISHINA, T ;
SASAKI, S ;
FUJITA, T .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (08) :853-856
[2]  
ASKEW DS, 1991, ONCOGENE, V6, P1915
[3]   Caspase-dependent apoptosis by ectopic expression of E2F-4 [J].
Chang, YC ;
Nakajima, H ;
Illenye, S ;
Lee, YS ;
Honjo, N ;
Makiyama, T ;
Fujiwara, I ;
Mizuta, N ;
Sawai, K ;
Saida, K ;
Mitsui, Y ;
Heintz, NH ;
Magae, J .
ONCOGENE, 2000, 19 (41) :4713-4720
[4]  
Chiba K, 1998, J IMMUNOL, V160, P5037
[5]  
EAMSHAW WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI DOI 10.1146/ANNUREV.BI0CHEM.68.1383
[6]   A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD [J].
Enari, M ;
Sakahira, H ;
Yokoyama, H ;
Okawa, K ;
Iwamatsu, A ;
Nagata, S .
NATURE, 1998, 391 (6662) :43-50
[7]   Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis [J].
Engels, IH ;
Stepczynska, A ;
Stroh, C ;
Lauber, K ;
Berg, C ;
Schwenzer, R ;
Wajant, H ;
Jänicke, RUU ;
Porter, AG ;
Belka, C ;
Gregor, M ;
Schulze-Osthoff, K ;
Wesselborg, S .
ONCOGENE, 2000, 19 (40) :4563-4573
[8]  
ENOZAWA S, 1996, IMMUNOPHARMACOLOGY, V34, P171
[9]   INDUCTION OF APOPTOSIS IN FIBROBLASTS BY C-MYC PROTEIN [J].
EVAN, GI ;
WYLLIE, AH ;
GILBERT, CS ;
LITTLEWOOD, TD ;
LAND, H ;
BROOKS, M ;
WATERS, CM ;
PENN, LZ ;
HANCOCK, DC .
CELL, 1992, 69 (01) :119-128
[10]  
FOTEDAR R, 1995, MOL CELL BIOL, V15, P932